Treatment of hidradenitis suppurativa with etanercept injection.

Author: AdamsDavid R, AndersonBryan E, FogelbergAnneli C, YankuraJessica A

Paper Details 
Original Abstract of the Article :
OBJECTIVES: To observe the effects of etanercept treatment on the cutaneous manifestations of hidradenitis suppurative (HS) and to evaluate physician and patient global assessment scores of cutaneous manifestations. DESIGN: Single-center, randomized, prospective, double-blind, placebo-controlled st...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1001/archdermatol.2010.72

データ提供:米国国立医学図書館(NLM)

Etanercept for Hidradenitis Suppurativa: A Disappointing Oasis

This research delves into the realm of skin disorders, exploring the effectiveness of etanercept, a tumor necrosis factor (TNF) inhibitor, for treating hidradenitis suppurativa (HS), a chronic inflammatory skin condition. Imagine a desert with a mirage that appears to offer relief from the scorching heat, but ultimately fades into disappointment. Similarly, HS can be a challenging condition, with its painful and debilitating symptoms. This study, like a weary traveler seeking a refreshing oasis, investigates the effectiveness of etanercept in alleviating the manifestations of HS. The researchers conducted a randomized, placebo-controlled study to assess the effects of etanercept, providing valuable insights into its potential as a treatment option.

Etanercept: A Disappointing Oasis

This study unfortunately reveals that etanercept did not demonstrate significant efficacy in treating HS. It's like encountering a mirage in the desert, promising relief but ultimately failing to deliver. The study's findings suggest that etanercept, while effective for other inflammatory conditions, may not be the answer for patients with HS.

Navigating the Desert of HS Treatment

This study underscores the importance of continuing research to find effective treatments for HS. It's like searching for a real oasis in the desert, a haven of relief from the scorching heat of this debilitating condition. The study's findings highlight the need for exploring alternative therapeutic approaches to manage HS and provide relief for patients.

Dr.Camel's Conclusion

This study explores the potential of etanercept for treating HS, but unfortunately finds it to be a disappointing oasis. It's like finding a mirage in the desert, promising relief but ultimately failing to deliver. However, the search for effective treatments for HS continues, and researchers are determined to find a real oasis of healing for those afflicted with this challenging condition.

Date :
  1. Date Completed 2010-06-07
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

20479297

DOI: Digital Object Identifier

10.1001/archdermatol.2010.72

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.